Cold Atmospheric Plasma for Clinical Purposes: Promising Results in Patients and Future Applications

  • Georg IsbaryEmail author
Conference paper
Part of the NATO Science for Peace and Security Series A: Chemistry and Biology book series (NAPSA)


Infected chronic wounds are both socioeconomic and medical problem. Cold atmospheric plasma (CAP) has already proven its efficacy in killing bacteria on agar plates but also the first prospective randomized controlled trial in patients. As an add-on therapy CAPs proved a highly significant decrease in bacterial load in 5 min plasma-treated wounds (34%, p < 10−6, n = 291, 36 patients) in comparison with wounds that received only standard wound care. This reduction is found in all kinds of germs, even multiresistant ones. Two minutes of plasma treatment led to a significant reduction in bacterial load as well (40%, p < 0.016, n = 70, 14 patients). The treatment is very well tolerated and no side effects occurred until now (in total more than 2,000 treatments in over 220 patients). The results of this study revealed the potential of atmospheric argon plasma treatment as a new approach to kill bacteria in terms of mutiresistancy. With the same CAP device other dermatologic diseases were treated successfully, e.g. Hailey-Hailey disease. New plasma devices using surrounding ambient air have not only greater bactericidal but also virucidal properties. These devices may herald a new era in public, personal, pet, and food hygiene, same as in decontamination. Investigations of human compatibility are promising.


Plasma Treatment Migration Rate Bacterial Load Plasma Device Cold Atmospheric Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29–40CrossRefGoogle Scholar
  2. 2.
    Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874–885CrossRefGoogle Scholar
  3. 3.
    Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, Cardo DM (2007) Estimating health care-associated infections and deaths in U.S. Hospitals, 2002. CDC Public Health Report March-April 122:160–166Google Scholar
  4. 4.
    Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and ­economic outcomes. Clin Infect Dis 36:1433–1437CrossRefGoogle Scholar
  5. 5.
    Etufugh CN, Phillips TJ (2007) Venous ulcers. Clin Dermatol 25:121–130CrossRefGoogle Scholar
  6. 6.
    Kurz X, Kahn SR, Abenhaim L, Clement D, Norgren L, Baccaglini U, Berard A, Cooke JP, Cornu-Thenard A, Depairon M, Dormandy JA, Durand-Zaleski I, Fowkes GR, Lamping DL, Partsch H, Scurr JH, Zuccarelli F (1999) VEINES task force report. Int Angiol 18(2):83–102Google Scholar
  7. 7.
    Heit JA (2002) Venous thromboembolism epidemiology. Semin Thromb Hemost 28(2):3–13CrossRefGoogle Scholar
  8. 8.
    Bogle MA, Arndt KA, Dover JS (2007) Evaluation of plasma skin regeneration technology in low-energy full-facial rejuvenation. Arch Dermatol 143:168–174CrossRefGoogle Scholar
  9. 9.
    Elsaie ML, Kammer JN (2008) Evaluation of plasma skin regeneration technology for cutaneous remodeling. J Cosmet Dermatol 7:309–311CrossRefGoogle Scholar
  10. 10.
    Kilmer S, Semchyshyn N, Shah G, Fitzpatrick R (2007) A pilot study on the use of a plasma skin regeneration device (Portrait: PSR3) in full facial rejuvenation procedures. Lasers Med Sci 22:101–109CrossRefGoogle Scholar
  11. 11.
    Shimizu T, Steffes B, Pompl R, Jamitzky F, Bunk W, Ramrath K, Georgi M, Stolz W, Schmidt HU, Urayama T, Fuji S, Morfill G (2008) Characterization of microwave plasma torch for decontamination. Plasma Process Polym 6:577–582CrossRefGoogle Scholar
  12. 12.
    Isbary G, Morfill G, Schmidt HU, Georgi M, Ramrath K, Heinlin J, Karrer S, Landthaler M, Shimizu T, Steffes B, Bunk W, Monetti R, Zimmermann JL, Pompl R, Stolz W (2010) A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol 163:78–82Google Scholar
  13. 13.
    Landsberg K, Neumann M, Haehnel M, Scharf C, Weltmann KD, von Woedtke T (2010) Atmospheric pressure plasma shows rapid regeneration of human cells. In: Proceedings of 3rd international conference on plasma medicine, Greifswald, Germany, 19–24 SeptGoogle Scholar
  14. 14.
    Topala I, Nastuta AV, Grigoras C, Dumitrascu N (2010) Study of oxidative stress markers during epithelial regeneration induced by atmospheric pressure plasma treatment. In: Proceedings of 3rd international conference on plasma medicine, Greifswald, Germany, 19–24 SeptGoogle Scholar
  15. 15.
    Keidar M, Volotskova O, Shashurin A, Stepp MA (2010) Plasma control of cell migration.In: Proceedings of 3rd international conference on plasma medicine, Greifswald, Germany, 19–24 SeptGoogle Scholar
  16. 16.
    Volotskova O, Shashurin A, Stepp MA, Pal-Ghosh S, Keidar M (2010) Plasma-controlled cell migration: localization of cold plasma-cell interaction region. Plasma Med 1:85–92CrossRefGoogle Scholar
  17. 17.
    Shekhter AB, Kabisov RK, Pekshee AV (1998) Byull Eksp Biol Med 8:210Google Scholar
  18. 18.
    Shekhter AB, Serezhenkov VA, Rudenko TG, Pekshev AV, Vanin AF (2005) Nitric Oxide Biol Chem 12:210CrossRefGoogle Scholar
  19. 19.
    Shulutko AM, Antropova NV, Kryuger YA (2008) Surgery 12:43Google Scholar
  20. 20.
    Isbary G, Morfill G, Zimmermann J, Shimizu T, Stolz W (2011) Cold atmospheric plasma a successful treatment of lesions in Hailey-Hailey Disease. Arch Dermatol 4:388–390CrossRefGoogle Scholar
  21. 21.
    Szigeti R, Kellermayer R (2006) Autosomal-dominant calcium ATPase disorders. J Invest Dermatol 11:2370–23765CrossRefGoogle Scholar
  22. 22.
    Cialfi S, Oliviero C, Ceccarelli S, Marchese C, Barbieri L, Biolcati G, Uccelletti D, Palleschi C, Barboni L, De Bernardo C, Grammatico P, Magrelli A, Salvatore M, Taruscio D, Frato L, Gulino A, Screpanti I, Talora C (2010) Complex multipathways alterations and oxidative stress are associated with Hailey–Hailey disease. Br J Dermatol 3:518–526CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Department of Dermatology, Allergology and Environmental MedicineHospital MunichMunichGermany

Personalised recommendations